首页> 外文期刊>Indian heart journal >Comparison of distal radial access versus standard transradial access in patients with smaller diameter radial Arteries(The distal radial versus transradial access in small transradial ArteriesStudy: D.A.T.A - S.T.A.R study)
【24h】

Comparison of distal radial access versus standard transradial access in patients with smaller diameter radial Arteries(The distal radial versus transradial access in small transradial ArteriesStudy: D.A.T.A - S.T.A.R study)

机译:较小直径径向动脉患者远端桡骨通道与标准桡骨通路的比较(小跨越术术中的远端径向桡动脉:D.A.T.A - S.T.A.R研究)

获取原文
           

摘要

Aims :To evaluate safety and efficacy of distal right radial access (DRRA) compared to right radial access (RRA), for coronary procedures, in patients with smaller diameter radial arteries (SDRA) (radial artery diameter (RAD)??2.1?mm). Methods and results This is a retrospective analysis of safety and efficacy of DRRA Vs. RRA in patients undergoing coronary procedures at our cardiac catheterization laboratories over a 10- month period between September 2017 and June, 2018 (first 5 calendar months with RRA-first; next 5 calendar months with DRRA-first). All patients underwent pre-procedure ultrasound of arm arteries. All patients had RAD2.1?mm (mean RAD 1.63?±?0.27?mm; RAD≤1.6?mm in 73.5%). Baseline characteristics were similar between groups. Primary end-point of puncture success was significantly lower in DRRA vs RRA group [79.5% vs 98.5%, p ?0.0001]. Puncture success was also lower in the subgroup of patients with RAD 1.6?mm?Vs.?≥?1.6?mm in the DRRA group ( p ?0.0001). The secondary end-point of puncture time was significantly higher (2.1?±?1.4?min vs. 1.0?±?0.45?min, p ?0.00001) in the DRRA Vs. RRA group. The occurrence of vascular access site complications (including access site hematomas), radial artery occlusion (RAO) and distal RAO at day 1 and day 30 were similar between RRA and DRRA groups.Non-vascular access-site complication was seen only in the DRRA group. Conclusion DRRA is a safe and effective access for coronary procedures; though technically challenging in patients with SDRA (RAD2.1?mm; mean RAD 1.63?±?0.27?mm), with lower puncture success and higher puncture time compared to RRA.
机译:旨在评估远端径向进入(DRRA)与右径向通道(RRA)的安全性和有效性,用于较小直径的径向动脉(SDRA)(桡动脉直径(rad)αα.<2.1 ?毫米)。方法和结果这是对DRRRA对的安全性和功效的回顾性分析。 RA在2017年9月和2018年6月至6月期间在我们的心脏导管术中进行的冠状动脉导管实验室(2018年6月至6月的第一个日历月份)(与RRA-First的前5个日历月份)进行过10个月的患者。所有患者均接受术前超声的臂动脉。所有患者均具有RAD <2.1Ωmm(平均rad1.63≤6.0.27Ω·mm;rad≤1.6×mm,在73.5%)。基线之间的基线特征在组之间相似。 DRRA VS RRA组的穿刺成功的主要终点 - 显着降低了[79.5%与98.5%,P <0.0001]。在DRRA组中的患者的亚组中,穿刺成功也较低,在DRA组中,≥≤≤1.6Ω·mm(P <0.0001)。穿刺时间的次要终点显着高(2.1?±1.4?min与1.0?±0.45?min,p& 0.00001)。 RRA集团。血管接入位点并发症(包括接入部位血液),桡动脉闭塞(RAO)和第30天的胃肠道和第30天的疾病的发生性在Rra和Drra Groups之间类似于DRRA的血管访问现场并发症团体。结论DRRA是一种安全有效的冠状动脉手术的获取;虽然在SDRA患者(RAD <2.1Ω·mm;平均1.63?±0.27Ω±±0.27Ω)患者中挑战,但与RRA相比,穿刺成功和更高的穿刺时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号